MONTVALE, N.J., Feb. 23, 2009 (GLOBE NEWSWIRE) -- Ivivi Technologies, Inc. (NASDAQ:IVVI), a leader in non-invasive, electroceutical(r) therapy systems designed to target and enhance the body’s anti-inflammatory response, today announced financial results for the third quarter of fiscal 2009 ended December 31, 2008.
